Select Medical - Public Comps and Valuation Multiples

Select Medical Overview

About Select Medical

Select Medical Holdings Corp is a healthcare company that operates through three segments: critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. Critical illness recovery hospitals which derives maximum revenue consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. Patients are typically admitted to critical illness recovery hospitals and rehabilitation hospitals from general acute care hospitals. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services.

Founded

2004

HQ

Employees

44.1K+

Website

selectmedicalholdings.com

Sectors

Hospitals & Clinics

Financials

LTM Revenue $5.4B

LTM EBITDA $518M

EV

$4.5B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Select Medical Financials

As of September 2025, Select Medical reported last 12-month revenue of $5.4B and EBITDA of $518M.

In the same period, Select Medical generated $558M in LTM gross profit and $159M in net income.

See Select Medical valuation multiples based on analyst estimates

Select Medical P&L

In the most recent fiscal year, Select Medical reported revenue of $5.2B and EBITDA of $507M.

Select Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Select Medical valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$5.4B	XXX	$5.2B	XXX	XXX	XXX
Gross Profit	$558M	XXX	$634M	XXX	XXX	XXX
Gross Margin	10%	XXX	12%	XXX	XXX	XXX
EBITDA	$518M	XXX	$507M	XXX	XXX	XXX
EBITDA Margin	10%	XXX	10%	XXX	XXX	XXX
EBIT	$350M	XXX	$268M	XXX	XXX	XXX
EBIT Margin	7%	XXX	5%	XXX	XXX	XXX
Net Profit	$159M	XXX	$214M	XXX	XXX	XXX
Net Margin	3%	XXX	4%	XXX	XXX	XXX
Net Debt	XXX	XXX	$1.7B	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Select Medical including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $5.4B. EBITDA for the last twelve months was $518M. In the most recent fiscal year, Select Medical achieved $5.2B in revenue and $507M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$5.4B	Analyst estimates available to subscribers	$5.2B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$558M	Analyst estimates available to subscribers	$634M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	10.4% gross margin	Analyst estimates available to subscribers	12.2% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$518M	Analyst estimates available to subscribers	$507M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	9.7% EBITDA margin	Analyst estimates available to subscribers	9.8% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$350M	Analyst estimates available to subscribers	$268M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	6.5% EBIT margin	Analyst estimates available to subscribers	5.2% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$159M	Analyst estimates available to subscribers	$214M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	3.0% net profit margin	Analyst estimates available to subscribers	4.1% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$1.7B	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Select Medical

This financial data table provides comprehensive performance metrics for Select Medical, a company based in United States of America. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Select Medical generated $5.4B in revenue over the last twelve months.
The company achieved $518M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $558M.
Net income over the last twelve months reached $159M.

Fiscal Year Performance

In the most recent fiscal year, Select Medical reported $5.2B in total revenue.
Fiscal year EBITDA was $507M.
The company maintained a gross profit margin of 12.2% in the most recent fiscal year.
EBITDA margin for the fiscal year was 9.8%.
Net profit margin reached 4.1% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Select Medical. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Select Medical Stock Performance

Select Medical has current market cap of $1.7B, and EV of $4.5B.

Market Cap Evolution

Select Medical Stock Data

As of October 17, 2025, Select Medical's stock price is $13.

See Select Medical trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$4.5B	$1.7B	XXX	XXX	XXX	XXX	$1.11

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Select Medical Valuation Multiples

Select Medical's trades at 0.9x EV/Revenue multiple, and 8.8x EV/EBITDA.

See valuation multiples for Select Medical and 15K+ public comps

Select Medical Financial Valuation Multiples

As of October 17, 2025, Select Medical has market cap of $1.7B and EV of $4.5B.

Equity research analysts estimate Select Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Select Medical has a P/E ratio of 10.5x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$1.7B	XXX	$1.7B	XXX	XXX	XXX
EV (current)	$4.5B	XXX	$4.5B	XXX	XXX	XXX
EV/Revenue	0.8x	XXX	0.9x	XXX	XXX	XXX
EV/EBITDA	8.7x	XXX	8.8x	XXX	XXX	XXX
EV/EBIT	12.8x	XXX	16.7x	XXX	XXX	XXX
EV/Gross Profit	8.0x	XXX	n/a	XXX	XXX	XXX
P/E	10.5x	XXX	7.8x	XXX	XXX	XXX
EV/FCF	31.7x	XXX	15.2x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Select Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Select Medical Margins & Growth Rates

Select Medical's last 12 month revenue growth is 5%

Select Medical's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $8K for the same period.

Select Medical's rule of 40 is 17% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Select Medical's rule of X is 22% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Select Medical and other 15K+ public comps

Select Medical Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	5%	XXX	5%	XXX	XXX	XXX
EBITDA Margin	10%	XXX	10%	XXX	XXX	XXX
EBITDA Growth	6%	XXX	-19%	XXX	XXX	XXX
Rule of 40	17%	XXX	15%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	22%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$8K	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	7%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial